1 - 10 of 82 articles
A British physician said a new antibiotic, actinospectacin, may be the answer to "deteriorating results" in the treatment of gonorrhea. Dr. R. R. Willcox of St. Mary's Hospital in London, said that in many areas of the world, gonorrhea is "largely uncontrolled and the numbers of new...
A patient's allergy to penicillin may soon be determined by a simple skin test, according to researchers at the International Congress of Dermatology. Two viewpoints were presented on a skin test substance known as penicilloyl-polylysine, which creates a reaction in some individuals with...
Problems and disadvantages of electronic patient monitoring were summarized at the recent American Hospital Association convention by Dr. Robert M. Farrier, assistant director of the clinical center at the National Institutes of Health.
Farrier drew upon personal experience,...
As a result of great advances in therapy the best weapon in the epidemiological control of leprosy is now its intensive treatment. By converting the "open case" to a "closed" one, the spread of the disease is minimized.
An essential parallel step is the systematic examination of...
References 1. Beck, C, et al.: Clin. Med. 7:519, 1960. 2. Teitel, L. H., et al.: Indust. Med. 29:150, 1960. 3. Billow, B.W.,et al.: Southwestern Med. 41:286,1960. 4. Clinical Reports to the Medical Department, Armour Pharmaceutical Company, 1960. 5. Taub, S. J.: Clin. Med. 7:2575, 1960.
AMA Conference on Aging Set for November in Buffalo
An AMA Regional Conference on Aging will be held Nov. 2-3 at the Statler-Hilton Hotel in Buffalo, N.Y. Participating states will be Connecticut, Delaware, Maine, Maryland, Massachusetts, New Hampshire, New Jersey,...
Radioisotopes as tools in the diagnosis and treatment of disease will be the subject of a half-day scientific session at the AMA Clinical Meeting in Los Angeles, Monday, Nov. 26.
Radioisotopes or tracer elements derived from the atomic energy pile can no longer be considered...
Chloroquine is giving researchers a scientific headache. On the one hand, the antimalarial drug appears to have a suppressive effect on skin cancers, while on the other hand, prolonged use may produce serious side effects, such as eye damage.
This was the conclusion of three...
Read and print from thousands of top scholarly journals.
Continue with Facebook
Sign up with Google
Log in with Microsoft
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.